BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23253260)

  • 1. Assessment of the usefulness of the murine cytotoxic T cell line CTLL-2 for immunotoxicity screening by transcriptomics.
    Schmeits PC; Volger OL; Zandvliet ET; van Loveren H; Peijnenburg AA; Hendriksen PJ
    Toxicol Lett; 2013 Feb; 217(1):1-13. PubMed ID: 23253260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DON shares a similar mode of action as the ribotoxic stress inducer anisomycin while TBTO shares ER stress patterns with the ER stress inducer thapsigargin based on comparative gene expression profiling in Jurkat T cells.
    Schmeits PC; Katika MR; Peijnenburg AA; van Loveren H; Hendriksen PJ
    Toxicol Lett; 2014 Jan; 224(3):395-406. PubMed ID: 24247028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure of Jurkat cells to bis (tri-n-butyltin) oxide (TBTO) induces transcriptomics changes indicative for ER- and oxidative stress, T cell activation and apoptosis.
    Katika MR; Hendriksen PJ; van Loveren H; Peijnenburg A
    Toxicol Appl Pharmacol; 2011 Aug; 254(3):311-22. PubMed ID: 21601586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome analysis of the human T lymphocyte cell line Jurkat and human peripheral blood mononuclear cells exposed to deoxynivalenol (DON): New mechanistic insights.
    Katika MR; Hendriksen PJ; Shao J; van Loveren H; Peijnenburg A
    Toxicol Appl Pharmacol; 2012 Oct; 264(1):51-64. PubMed ID: 22846391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytological and biochemical analysis of the mode of action of bis (tri-n-butyltin) tri-oxide (TBTO) in Jurkat cells.
    Katika MR; Hendriksen PJ; de Ruijter NC; van Loveren H; Peijnenburg A
    Toxicol Lett; 2012 Jul; 212(2):126-36. PubMed ID: 22613032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomics analysis of primary mouse thymocytes exposed to bis(tri-n-butyltin)dioxide (TBTO).
    van Kol SW; Hendriksen PJ; van Loveren H; Peijnenburg A
    Toxicology; 2012 Jun; 296(1-3):37-47. PubMed ID: 22434021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the mechanism of immunotoxicity of cyclosporine A in murine in vitro and in vivo models.
    Schmeits PC; Schaap MM; Luijten M; van Someren E; Boorsma A; van Loveren H; Peijnenburg AA; Hendriksen PJ
    Arch Toxicol; 2015 Dec; 89(12):2325-37. PubMed ID: 25224403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the modes of action of deoxynivalenol (DON) in the human Jurkat T-cell line.
    Katika MR; Hendriksen PJ; van Loveren H; A C M Peijnenburg A
    J Immunotoxicol; 2015; 12(3):206-16. PubMed ID: 24988111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro immunotoxicity of bis(tri-n-butyltin)oxide (TBTO) studied by toxicogenomics.
    Baken KA; Arkusz J; Pennings JLA; Vandebriel RJ; van Loveren H
    Toxicology; 2007 Jul; 237(1-3):35-48. PubMed ID: 17553608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
    Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
    Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome-based functional classifiers for direct immunotoxicity.
    Shao J; Berger LF; Hendriksen PJ; Peijnenburg AA; van Loveren H; Volger OL
    Arch Toxicol; 2014 Mar; 88(3):673-89. PubMed ID: 24356939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of deoxynivalenol on gene expression in the murine thymus.
    van Kol SW; Hendriksen PJ; van Loveren H; Peijnenburg A
    Toxicol Appl Pharmacol; 2011 Feb; 250(3):299-311. PubMed ID: 21074547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 May; 134(5):3396-403. PubMed ID: 2984289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis of genes involved in apoptosis, proliferation and endoplasmic reticulum stress in ionomycin/PMA treated Jurkat cells.
    Stankov K; Bogdanovic G; Stankov S; Draskovic D; Grubor-Lajsic G; Spasic M; Blagojevic D
    J BUON; 2012; 17(2):369-76. PubMed ID: 22740220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of competing apoptotic and survival signaling pathways in the macrophage by the ribotoxic trichothecene deoxynivalenol.
    Zhou HR; Islam Z; Pestka JJ
    Toxicol Sci; 2005 Sep; 87(1):113-22. PubMed ID: 15976193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CXCL12-mediated chemotaxis of Jurkat cells by direct immunotoxicants.
    Shao J; Stout I; Volger OL; Hendriksen PJ; van Loveren H; Peijnenburg AA
    Arch Toxicol; 2016 Jul; 90(7):1685-94. PubMed ID: 26314263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of glucocorticoids on the proliferation of a murine helper and a cytolytic T cell clone in response to IL-2 and IL-4.
    Bertoglio JH; Leroux E
    J Immunol; 1988 Aug; 141(4):1191-6. PubMed ID: 2969398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes.
    Inge TH; McCoy KM; Susskind BM; Barrett SK; Zhao G; Bear HD
    J Immunol; 1992 Jun; 148(12):3847-56. PubMed ID: 1602133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using CTLL-2 and CTLL-2 bcl2 cells to avoid interference by apoptosis in the in vitro micronucleus test.
    Meintières S; Biola A; Pallardy M; Marzin D
    Environ Mol Mutagen; 2003; 41(1):14-27. PubMed ID: 12552588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.